Literature DB >> 15572109

Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation.

Xavier Drouot1, Satoru Oshino, Bechir Jarraya, Laurent Besret, Haruhiko Kishima, Philippe Remy, Julien Dauguet, Jean Pascal Lefaucheur, Frédéric Dollé, Françoise Condé, Michel Bottlaender, Marc Peschanski, Yves Kéravel, Philippe Hantraye, Stéphane Palfi.   

Abstract

A concept in Parkinson's disease postulates that motor cortex may pattern abnormal rhythmic activities in the basal ganglia, underlying the genesis of observed motor symptoms. We conducted a preclinical study of electrical interference in the primary motor cortex using a chronic MPTP primate model in which dopamine depletion was progressive and regularly documented using 18F-DOPA positron tomography. High-frequency motor cortex stimulation significantly reduced akinesia and bradykinesia. This behavioral benefit was associated with an increased metabolic activity in the supplementary motor area as assessed with 18-F-deoxyglucose PET, a normalization of mean firing rate in the internal globus pallidus (GPi) and the subthalamic nucleus (STN), and a reduction of synchronized oscillatory neuronal activities in these two structures. Motor cortex stimulation is a simple and safe procedure to modulate subthalamo-pallido-cortical loop and alleviate parkinsonian symptoms without requiring deep brain stereotactic surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572109     DOI: 10.1016/j.neuron.2004.11.023

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  36 in total

Review 1.  Restoration of locomotive function in Parkinson's disease by spinal cord stimulation: mechanistic approach.

Authors:  Romulo Fuentes; Per Petersson; Miguel A L Nicolelis
Journal:  Eur J Neurosci       Date:  2010-10       Impact factor: 3.386

Review 2.  Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature.

Authors:  F Fregni; D K Simon; A Wu; A Pascual-Leone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.

Authors:  Antonio P Strafella; Ji Hyun Ko; Oury Monchi
Journal:  Neuroimage       Date:  2006-03-20       Impact factor: 6.556

4.  Numerical optimization of coordinated reset stimulation for desynchronizing neuronal network dynamics.

Authors:  Shigeru Kubota; Jonathan E Rubin
Journal:  J Comput Neurosci       Date:  2018-06-07       Impact factor: 1.621

Review 5.  Mechanisms and targets of deep brain stimulation in movement disorders.

Authors:  Matthew D Johnson; Svjetlana Miocinovic; Cameron C McIntyre; Jerrold L Vitek
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 6.  Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.

Authors:  David Lindenbach; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2013-10-07       Impact factor: 8.989

Review 7.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

8.  Spinal cord stimulation restores locomotion in animal models of Parkinson's disease.

Authors:  Romulo Fuentes; Per Petersson; William B Siesser; Marc G Caron; Miguel A L Nicolelis
Journal:  Science       Date:  2009-03-20       Impact factor: 47.728

9.  Subthalamic nucleus neurons are synchronized to primary motor cortex local field potentials in Parkinson's disease.

Authors:  Shoichi A Shimamoto; Elena S Ryapolova-Webb; Jill L Ostrem; Nicholas B Galifianakis; Kai J Miller; Philip A Starr
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

Review 10.  Motor cortex stimulation for pain and movement disorders.

Authors:  Jeffrey E Arle; Jay L Shils
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.